| Biocitech, a life sciences technology park,
has recently announced plans to double its size
over the next 10 years. There are already 26
companies established at Biocitech, situated
within easy reach of Paris’ city centre and Charles
de Gaulle airport.
They represent a wide range
of complementary disciplines covering drug
discovery, chemistry, computing technology,
genetics, non-medicinal health products and
various support activities. The pathologies studied
include cancer, inflammatory and infectious
diseases, diseases of the bones and joints,
neurodegenerative diseases and thrombosis.
The companies in the park show a track record of consistent success. They filed more than 30 patent applications in 2007 – a figure which
puts Biocitech in third place for the number of filings in the life
sciences... |
